Key facts
- It has raised $90K; the latest was Angel (individual) ($90K) in Jan 2026.
- CardiaPath has filed 1 Form D with the SEC, most recently Jan 2026 ($90K sold to 4 investors).
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for CardiaPath
- ·The full record, as it builds
Funding rounds
No funding rounds for CardiaPath are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CardiaPath
Provider of AI-enabled home-based cardiology care designed to help patients manage heart health daily while enabling clinicians to deliver proactive, data-driven care. The company offers wearable data, personalized care pathways, virtual cardiac rehabilitation, and an AI health coach in a single connected platform, enabling clients to stay engaged in everyday heart care while giving clinicians structured insights that improve outcomes, efficiency, and long-term adherence.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2025
- Website
- cardiapath.com/
- Ownership
- Privately Held (backing)
CardiaPath doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CardiaPath shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CardiaPath in its N-PORT filings yet. We sweep new filings monthly.